GUERIN MARK PATRICK (Chief Financial Officer) purchased 19.6% of their position (21.37K shares) of TRAWS PHARMA, INC. on the open market
Open‑market purchase worth $5.6K — a significant purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/30/2020ACC: 0001179110-20-011470
Officer· Chief Financial Officer
Since Jul 2018
+21.37K
Net shares
Net buyer
$5.6K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
21.37K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+16.75K
Price / share
$0.26
Trade value
$4.36K
% of position
15.4%
11/25/2020
108.84K→125.60K
Common Stock
Direct
Shares
+4.61K
Price / share
$0.26
Trade value
$1.20K
% of position
3.7%
11/27/2020
125.60K→130.21K
Total
Net shares
+21.37K
Net value
$5.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/25/2020 | P · Purchase | +16.75K | $0.26 | $4.36K | 15.4% | 108.84K | 125.60K |
| Common Stock Direct | 11/27/2020 | P · Purchase | +4.61K | $0.26 | $1.20K | 3.7% | 125.60K | 130.21K |
| Total | +21.37K | $5.56K | ||||||
Derivative Transactions0
No derivative transactions reported